87 results
10-Q
2024 Q1
TCBP
TC BioPharm (Holdings) plc
15 May 24
Quarterly report
4:06pm
and cash equivalents
Corporation tax receivable
Prepaid expenses and other current assets
Total current assets
Non-current assets:
Property and equipment … ):
Change in fair value of derivative liability
Other expense, net
Total other income (expense), net
Net loss before income taxes
Income tax credit
Net loss
8-K
EX-4.1
TCBP
TC BioPharm (Holdings) plc
8 May 24
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
8:55am
. Issuance of Warrant ADSs shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance … by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto
10-K/A
2023 FY
TCBP
TC BioPharm (Holdings) plc
29 Apr 24
Annual report (amended)
5:23pm
is a summary and description of fees incurred by Marcum LLP for the years ended December 31, 2023, and 2022:
Audit fees (1)
Tax fees
All other fees
Total fees
10-K
2023 FY
EX-97.1
TCBP
TC BioPharm (Holdings) plc
1 Apr 24
Annual report
5:11pm
received by the Executive on a pre-tax basis. The date of receipt of the Compensation depends upon the terms of the award of such Compensation … provide such opinion to the exchange or association); or (C) recovery would likely cause an otherwise tax-qualified retirement plan, under which
10-K
x84dfu
1 Apr 24
Annual report
5:11pm
6-K
EX-10.3
str2g
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
6-K
EX-10.2
23ahxf4
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
6-K
EX-10.1
5ajo16i
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
6-K
EX-10.4
jymjih7vm
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
424B4
0bgxsy4s17mazrnmwh
20 Dec 23
Prospectus supplement with pricing info
6:42pm
F-1/A
0vov7j j1imlbdt
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.19
fia8o at9n69er21o
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.20
amsa3md29
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.21
5qxh0t2 mk
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-10.7
zta84cfcweec
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
424B3
2p3 n2em45g1cwad9n27
8 Nov 23
Prospectus supplement
4:05pm
F-3/A
vhhmbpwpkopo36ijpuj1
2 Nov 23
Shelf registration (foreign) (amended)
1:11pm
6-K
EX-99.1
22mz1gfv9
2 Nov 23
Current report (foreign)
12:57pm
6-K
EX-99.2
b4pab5j
2 Nov 23
Current report (foreign)
12:57pm